Machine Learning-Based Ensemble Recursive Feature Selection of Circulating miRNAs for Cancer Tumor Classification
暂无分享,去创建一个
Alexander Schönhuth | Alejandro Lopez-Rincon | Lucero Mendoza-Maldonado | Marlet Martinez-Archundia | Aletta D Kraneveld | Johan Garssen | Alberto Tonda | A. Kraneveld | J. Garssen | M. Martínez-Archundia | A. Tonda | A. Schönhuth | Lucero Mendoza-Maldonado | A. Lopez-Rincon
[1] Ben Davidson,et al. Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker , 2014, BMC Cancer.
[2] Thibault Helleputte,et al. Robust biomarker identification for cancer diagnosis with ensemble feature selection methods , 2010, Bioinform..
[3] Hiroshi Kono,et al. miR-122-5p as a novel biomarker for alpha-fetoprotein-producing gastric cancer , 2018, World journal of gastrointestinal oncology.
[4] Ash A. Alizadeh,et al. Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients , 2018, Scientific Reports.
[5] Estrid Høgdall,et al. Early metastatic colorectal cancers show increased tissue expression of miR-17/92 cluster members in the invasive tumor front. , 2018, Human pathology.
[6] Fan Li,et al. Overexpression of E2F mRNAs Associated with Gastric Cancer Progression Identified by the Transcription Factor and miRNA Co-Regulatory Network Analysis , 2015, PloS one.
[7] Stijn van Dongen,et al. miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..
[8] A. Stegh. Targeting the p53 signaling pathway in cancer therapy – the promises, challenges and perils , 2012, Expert opinion on therapeutic targets.
[9] Jianjun Chen,et al. MicroRNAs in cancer biology and therapy: Current status and perspectives , 2014, Genes & diseases.
[10] Xiaoyi Mi,et al. MiR-630 inhibits cells migration and invasion by targeting SOX 4 in triple-negative breast cancer , 2016 .
[11] M. Newton,et al. Genes Involved in DNA Repair and Nitrosamine Metabolism and Those Located on Chromosome 14q32 Are Dysregulated in Nasopharyngeal Carcinoma , 2006, Cancer Epidemiology Biomarkers & Prevention.
[12] Xiao-guang Liu,et al. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer , 2012, Medical Oncology.
[13] Yan He,et al. Identification of Serum MicroRNAs as Novel Biomarkers in Esophageal Squamous Cell Carcinoma Using Feature Selection Algorithms , 2019, Front. Oncol..
[14] Qiang Wang,et al. MiRNAs as Biomarkers of Myocardial Infarction: A Meta-Analysis , 2014, PloS one.
[15] Taek-Kyun Kim,et al. Current State of Circulating MicroRNAs as Cancer Biomarkers. , 2015, Clinical chemistry.
[16] Zhonghu Bai,et al. Breast cancer intrinsic subtype classification, clinical use and future trends. , 2015, American journal of cancer research.
[17] Francesco Falciani,et al. GALGO: an R package for multivariate variable selection using genetic algorithms , 2006, Bioinform..
[18] David S. Marco Antonio,et al. MiR-708-5p as a Predictive Marker of Colorectal Cancer Prognosis , 2016 .
[19] Sheau-Fang Yang,et al. Periostin overexpression is associated with worse prognosis in nasopharyngeal carcinoma from endemic area: a cohort study , 2018, OncoTargets and therapy.
[20] Peng Huang,et al. Identification of MicroRNA‐214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression , 2014, Hepatology.
[21] V. Kim,et al. The Drosha-DGCR8 complex in primary microRNA processing. , 2004, Genes & development.
[22] Francisco Martínez,et al. Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy. , 2014, The Journal of urology.
[23] Federico Ambrogi,et al. Assessing Agreement between miRNA Microarray Platforms , 2014, Microarrays.
[24] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[25] M. Blasco,et al. Cellular Senescence in Cancer and Aging , 2007, Cell.
[26] F. Slack,et al. miRNA modulation of the cellular stress response. , 2008, Future oncology.
[27] Jiang Lin,et al. Association between mir-24 and mir-378 in formalin-fixed paraffin-embedded tissues of breast cancer. , 2014, International journal of clinical and experimental pathology.
[28] Hong Cao,et al. Low-level expression of let-7a in gastric cancer and its involvement in tumorigenesis by targeting RAB40C. , 2011, Carcinogenesis.
[29] Sercan Ergün,et al. The association of the expression of miR-122-5p and its target ADAM10 with human breast cancer , 2014, Molecular Biology Reports.
[30] Alex E. Lash,et al. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..
[31] Yu-Hang Zhang,et al. Identifying circulating miRNA biomarkers for early diagnosis and monitoring of lung cancer. , 2020, Biochimica et biophysica acta. Molecular basis of disease.
[32] Bo Zhu,et al. Identification of a serum microRNA expression signature for detection of lung cancer, involving miR-23b, miR-221, miR-148b and miR-423-3p. , 2017, Lung cancer.
[33] M. Tewari,et al. MicroRNA profiling: approaches and considerations , 2012, Nature Reviews Genetics.
[34] Osamu Hori,et al. Cellular Stress Responses: Cell Survival and Cell Death , 2010, International journal of cell biology.
[35] Rajvir Dahiya,et al. MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. , 2011, Cancer research.
[36] G. Cheng,et al. Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy. , 2015, Advanced drug delivery reviews.
[37] Fang Wu,et al. Upregulated exosomic miR-23b-3p plays regulatory roles in the progression of pancreatic cancer , 2017, Oncology reports.
[38] Pierosandro Tagliaferri,et al. miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling , 2018, Journal of Experimental & Clinical Cancer Research.
[39] Verónica Bolón-Canedo,et al. Ensemble feature selection: Homogeneous and heterogeneous approaches , 2017, Knowl. Based Syst..
[40] Subrata Sen,et al. Tumor-Associated Circulating MicroRNAs as Biomarkers of Cancer , 2014, Molecules.
[41] Guo-Qiang Chen,et al. MiR-630 suppresses breast cancer progression by targeting metadherin , 2015, Oncotarget.
[42] Gaël Varoquaux,et al. Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..
[43] Yvan Saeys,et al. Robust Feature Selection Using Ensemble Feature Selection Techniques , 2008, ECML/PKDD.
[44] Meng Li,et al. Topologically inferring active miRNA‐mediated subpathways toward precise cancer classification by directed random walk , 2019, Molecular oncology.
[45] Wei Cai,et al. miR-708 promotes the development of bladder carcinoma via direct repression of Caspase-2 , 2013, Journal of Cancer Research and Clinical Oncology.
[46] Yang Zhao,et al. A Systematic Evaluation of Feature Selection and Classification Algorithms Using Simulated and Real miRNA Sequencing Data , 2015, Comput. Math. Methods Medicine.
[47] Yisrael Parmet,et al. Differences in microRNA detection levels are technology and sequence dependent. , 2013, RNA.
[48] Anindya Dutta,et al. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. , 2007, Genes & development.
[49] Yong Li,et al. The p53 Pathway Encounters the MicroRNA World , 2009, Current genomics.
[50] Juan Liu,et al. MicroRNA Control of p53 , 2017, Journal of cellular biochemistry.
[51] Benjamin Piwowarski,et al. Evolutionary optimization of convolutional neural networks for cancer miRNA biomarkers classification , 2018, Appl. Soft Comput..
[52] Hiroshi I. Suzuki,et al. Modulation of microRNA processing by p53 , 2009, Nature.
[53] Hosuk Lee,et al. Biogenesis and regulation of the let-7 miRNAs and their functional implications , 2015, Protein & Cell.
[54] Chang-Hua Kou,et al. Downregulation of mir-23b in plasma is associated with poor prognosis in patients with colorectal cancer. , 2016, Oncology letters.
[55] C. Lutz,et al. miR-708-5p: a microRNA with emerging roles in cancer , 2017, Oncotarget.
[56] Hongwei Liang,et al. miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer , 2014, Molecular Cancer.
[57] F. Lovat,et al. Non-Coding RNAs and Cancer , 2013, International journal of molecular sciences.
[58] Leng Han,et al. Integrated genomic analysis of recurrence-associated small non-coding RNAs in oesophageal cancer , 2016, Gut.
[59] Maria Peña-Chilet,et al. MicroRNA profile in very young women with breast cancer , 2014, BMC Cancer.
[60] N. Villegas-Sepúlveda,et al. New insights into radioresistance in breast cancer identify a dual function of miR‐122 as a tumor suppressor and oncomiR , 2019, Molecular oncology.
[61] Christina Backes,et al. Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic Patients. , 2020, JAMA oncology.
[62] Jing Li,et al. miR-145 inhibits breast cancer cell growth through RTKN. , 2009, International journal of oncology.
[63] Alberto Inga,et al. A Cross-Platform Comparison of Affymetrix and Agilent Microarrays Reveals Discordant miRNA Expression in Lung Tumors of c-Raf Transgenic Mice , 2013, PloS one.
[64] Zhifu Sun,et al. Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers , 2012, Clinical Cancer Research.
[65] Q. Zou,et al. Cancer Diagnosis Through IsomiR Expression with Machine Learning Method , 2016 .
[66] Maryam Zare,et al. Aberrant miRNA promoter methylation and EMT‐involving miRNAs in breast cancer metastasis: Diagnosis and therapeutic implications , 2018, Journal of cellular physiology.
[67] Yazeed A Al-Sheikh,et al. Expression profiling of selected microRNA signatures in plasma and tissues of Saudi colorectal cancer patients by qPCR , 2015, Oncology letters.
[68] G. Mills,et al. miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-α in human breast cancer cells , 2010, Cell Death and Differentiation.
[69] Alessandro Salvi,et al. Functional Role of microRNA-23b-3p in Cancer Biology. , 2018, MicroRNA.
[70] J. Mandrekar. Receiver operating characteristic curve in diagnostic test assessment. , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[71] S. Zhong,et al. miR-221/222: promising biomarkers for breast cancer , 2013, Tumor Biology.
[72] Kui Liu,et al. Let-7a inhibits growth and migration of breast cancer cells by targeting HMGA1. , 2015, International journal of oncology.
[73] Jian Zhang,et al. Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells , 2014, Breast Cancer Research and Treatment.
[74] S. Batra,et al. MUC4 as a diagnostic marker in cancer. , 2008, Expert opinion on medical diagnostics.
[75] Ru-Fang Yeh,et al. TRPS1 Targeting by miR-221/222 Promotes the Epithelial-to-Mesenchymal Transition in Breast Cancer , 2011, Science Signaling.
[76] Francesca Demichelis,et al. Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression. , 2013, Cancer research.
[77] Domenico Coppola,et al. MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer* , 2008, Journal of Biological Chemistry.
[78] A. Šimundić. Measures of Diagnostic Accuracy: Basic Definitions , 2009, EJIFCC.
[79] C. Lawrie,et al. New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies , 2016, International journal of molecular sciences.
[80] Jing-Tao Huang,et al. MicroRNA Machinery Genes as Novel Biomarkers for Cancer , 2014, Front. Oncol..
[81] Minoru Kanehisa,et al. KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..
[82] Domenico Coppola,et al. MicroRNA-221/222 negatively regulates estrogen receptor α and is associated with tamoxifen resistance in breast cancer. , 2016, The Journal of Biological Chemistry.
[83] S. Knudsen,et al. A 4-miRNA signature to predict survival in glioblastomas , 2017, PloS one.
[84] Songbo Xie,et al. Therapeutic targeting of cellular stress responses in cancer , 2018, Thoracic cancer.
[85] S. Pfeffer,et al. miR-122--a key factor and therapeutic target in liver disease. , 2015, Journal of hepatology.
[86] P. M. Das,et al. Downregulation of miR-342 is associated with tamoxifen resistant breast tumors , 2010, Molecular Cancer.
[87] Kalpana Ghoshal,et al. miR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimir. , 2015, Current gene therapy.
[88] Jun Zhang,et al. Up-Regulation of Plasma miR-23b is Associated with Poor Prognosis of Gastric Cancer , 2016, Medical science monitor : international medical journal of experimental and clinical research.
[89] V. Kim. MicroRNA biogenesis: coordinated cropping and dicing , 2005, Nature Reviews Molecular Cell Biology.
[90] Robert Gentleman,et al. Using GOstats to test gene lists for GO term association , 2007, Bioinform..
[91] Merve Mutlu,et al. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance , 2016, Journal of Molecular Medicine.
[92] Jin-hai Tang,et al. miR-342 is associated with estrogen receptor-α expression and response to tamoxifen in breast cancer , 2013, Experimental and therapeutic medicine.
[93] M. Iorio,et al. Loss of function of miR-342-3p results in MCT1 over-expression and contributes to oncogenic metabolic reprogramming in triple negative breast cancer , 2018, Scientific Reports.
[94] Wei Zhao,et al. Induction of microRNA-let-7a inhibits lung adenocarcinoma cell growth by regulating cyclin D1 , 2018, Oncology reports.
[95] E. Howe,et al. Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers , 2009, Journal of oncology.
[96] Cesare Furlanello,et al. A Comparison of MCC and CEN Error Measures in Multi-Class Prediction , 2010, PloS one.
[97] Sriparna Saha,et al. A Stack-based Ensemble Framework for Detecting Cancer MicroRNA Biomarkers , 2017, Genom. Proteom. Bioinform..
[98] Alberto Tonda,et al. Automatic discovery of 100-miRNA signature for cancer classification using ensemble feature selection , 2019, BMC Bioinformatics.
[99] Nicholas Bertos,et al. miR-378(∗) mediates metabolic shift in breast cancer cells via the PGC-1β/ERRγ transcriptional pathway. , 2010, Cell metabolism.
[100] Alejandro Lopez-Rincon,et al. Ensemble Feature Selection and Meta-Analysis of Cancer miRNA Biomarkers , 2018, bioRxiv.
[101] Zheng Wang,et al. miR‐122‐5p promotes aggression and epithelial‐mesenchymal transition in triple‐negative breast cancer by suppressing charged multivesicular body protein 3 through mitogen‐activated protein kinase signaling , 2020, Journal of cellular physiology.
[102] V. Kim,et al. MicroRNA maturation: stepwise processing and subcellular localization , 2002, The EMBO journal.
[103] Wang Jing,et al. Plasma microRNA profiles for bladder cancer detection. , 2013, Urologic oncology.
[104] Paula Ribeiro,et al. miRNet - dissecting miRNA-target interactions and functional associations through network-based visual analysis , 2016, Nucleic Acids Res..